For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

You’ve just been given a new medicine, and you’ve read its consumer medicine information (CMI) leaflet. But, your condition is not mentioned in the list of conditions the medicine is used for. Does that matter? Should you talk to your doctor?
Can the medicine be used for other conditions?The first situation where off-label prescribing may occur is where good quality research shows that the medicine works and is safe when used for the unapproved condition. This situation may arise if the medicine’s effectiveness for the condition was discovered after the medicine was first approved, and the company that makes the medicine has not yet applied to have the additional condition approved by the Government.
The second situation where off-label prescribing may occur is where the medicine is being used as part of an official clinical trial to determine whether it is indeed safe and effective for the condition.
The third situation where off-label prescribing occurs is to treat people with serious or rare medical conditions whose exceptional circumstances mean that there are no approved medicines that can be prescribed for them.
Many medicines are tested only in adults. If so, the medicine may be approved only for use with adults.
Because children’s bodies handle medicines differently to adults, doctors cannot be sure that a medicine tested only in adults will work the same way for children. Therefore, some medicines tested only in adults are not approved for use by children.
The children most likely to be prescribed medicines off-label are those being treated in hospital for serious conditions for which there are no medicines approved for use with children.
In Australia, the cost of most prescription medicines is subsidised by the Government under the Pharmaceutical Benefits Scheme (PBS). However, the Scheme only covers medicines prescribed for approved uses. If you have been prescribed a medicine off-label, you may have to pay the full price of the medicine.
Doctors are strongly encouraged by medical authorities to tell you if they are prescribing a medicine off-label, and to highlight any uncertainties about its potential side effects and benefits for you and your condition. They are also encouraged to obtain your written consent.
If your doctor prescribes a medicine for you off-label, ask them any questions you may have. In particular, ask why they think it would be useful for you, and if there are any uncertainties about its potential benefits and side effects. Similarly, ask these questions if your condition does not appear in the consumer medicine information (CMI) leaflet for the medicine.
Asking these questions does not mean that you’re being rude or disrespectful. Rather, it means that you’re taking an active role in your healthcare and getting the information you need to be well informed about your treatment.
MedicinesTalk is a free quarterly newsletter for consumers written by consumers about using medicines wisely. Subscribe to the hard copy version using our online ordering system, or write to MedicinesTalk, National Prescribing Service Limited, PO Box 1147, Strawberry Hills, NSW 2012.
Date published: 2012-01-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.